Spectranetics Corp (NASDAQ:SPNC)

24.33
Delayed Data
As of May 01
 -1.32 / -5.15%
Today’s Change
20.07
Today|||52-Week Range
37.04
-29.64%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$1.0B

Company Description

The Spectranetics Corp. is a medical device company that develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. Its products are used to treat arterial blockages in the heart and legs as well as the removal of pacemaker and defibrillator leads. It has two reportable segments, which were identified on a geographic basis: U.S.Medical and International Medical. These segments offer the same products and services but operate in different geographic regions, with different distribution networks and different regulatory environments. Within U.S. Medical, the company aggregates its two business units, Vascular Intervention and Lead Management. The Vascular Intervention business line manufactures and sells a range of peripheral and cardiac laser catheters for ablation of stenosed and occluded arteries above and below the knee and within coronary arteries. The Lead Management business line includes the manufacturing of excimer laser sheaths and cardiac lead management accessories, including lead locking stylets for manual traction and aid in laser-assisted extraction of cardiac pacemaker and defibrillator leads. Spectranetics was founded by Robert Golobic, Johan Sverdrup and Richard T. Simko in 1984 and is headquartered in Colorado Springs, CO.

Contact Information

The Spectranetics Corp.
9965 Federal Drive
Colorado Springs Colorado 80921-3617
P:(719) 633-8333
Investor Relations:
171963383332415

Employees

Shareholders

Mutual fund holders57.47%
Other institutional52.65%
Individual stakeholders5.13%

Top Executives

Scott William DrakePresident, Chief Executive Officer & Director
Shahriar MatinChief Operating Officer
Guy A. ChildsCFO, Vice President & Head-Investor Relations
Wade A. BoweVice President-Research & Development
Paul GardonSenior Vice President & General Counsel

To view my watchlist

Not a member yet?

Sign up now for a free account